The mitochondrion of Trypanosoma brucei lacks tRNA genes. Its translation system therefore depends on the import of cytosolic, nucleus-encoded tRNAs. Thus, most trypanosomal tRNAs function in both the cytosol and the mitochondrion, and all are of the eukaryotic type. This is also the case for the elongator tRNA Met , whereas the only other trypanosomal tRNA Met , the eukaryotic initiator, is found exclusively in the cytosol. Unlike their cytosolic counterparts, organellar initiator tRNAs Met carry a formylated methionine. This raises the question of how initiation of translation works in trypanosomal mitochondria, where only elongator tRNA Met is found. Using in organello charging and formylation assays, we show that unexpectedly a fraction of elongator tRNA Met becomes formylated after import into mitochondria. Furthermore, in vitro experiments with mitochondrial extracts demonstrate that only the trypanosomal elongator and not the initiator tRNA Met is recognized by the formylation activity. Finally, RNA interference assays identify the gene encoding the trypanosomal formylase activity. Whereas the predicted protein is homologous to prokaryotic and mitochondrial methionyl-tRNA Met formyltransferases, it has about twice the mass of any of these proteins. mitochondrial translation ͉ initiator tRNA Met ͉ formylation ͉ mitochondrial tRNA import ͉ methionyl-tRNA Met formyltransferase
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mitochondrial translation ͉ initiator tRNA Met ͉ formylation ͉ mitochondrial tRNA import ͉ methionyl-tRNA Met formyltransferase I nitiation of protein synthesis occurs universally with the amino acid methionine in eukaryotes and Archea or its derivative formyl-methionine in Bacteria and organelles. All organisms have two classes of tRNAs Met , an initiator tRNA Met-i , which is used for initiation of protein synthesis, and an elongator tRNA Met-e , which functions in the insertion of methionine into internal peptidic linkages (1, 2) . Whereas elongator tRNAs Met-e of all organisms look similar, there are two distinct groups of initiator tRNAs Met-i . Bacterial and organellar initiator tRNAs Met-i are only functional when carrying a formylated methionine. Addition of the formyl group to the methionine of the charged initiator tRNA Met-i is catalyzed by methionyltRNA Met formyltransferase (MTF), which is found in Bacteria and organelles but not in Archea or the eukaryotic cytosol. It recognizes specific features of the tRNA such as the CA mismatch at the top of the acceptor stem (position 1-72), which is conserved in bacterial initiator tRNAs Met-i . Initiator tRNAs Met-i of the eukaryotic cytosol and Archea, on the other hand, carry an A1⅐T72 base pair, which is not found in any other tRNA. Mitochondrial tRNAs Met are less clearly defined. Often, only a single type of tRNA Met is found, which is assumed to be used as an initiator in the formylated state and as an elongator when carrying an underivatized methionine (3) . If only a single tRNA Met is found in mitochondria, it most closely resembles an initiator type; however, frequently an A1⅐T72 base pair replaces the typical C1⅐A72 mismatch. Thus, many mitochondrial tRNAs Met superficially resemble eukaryotic initiator tRNAs Met-i . Whereas in many eukaryotes all of the tRNAs necessary for organellar translation are encoded on the mitochondrial genome, there is a large variety of organisms where a variable number of apparently essential mitochondrial tRNA genes are missing. It has been shown that the lack of these genes is generally compensated by import of the corresponding cytosolic tRNAs. In all cases known, imported tRNAs originate from nuclear genes encoding cytosolic, eukaryotic-type tRNAs involved in cytosolic translation (4) . An extreme situation is found in the trypanosomatids, which have lost their entire set of mitochondrial tRNA genes and therefore must import all tRNAs necessary for organellar protein synthesis (5, 6) . In these organisms, the bacterial-type translation system of mitochondria is faced with the problem that it has to function with imported, eukaryotic-type tRNAs only. This raises the question of how mitochondrial translation initiation, known to require a formylated bacterial-type initiator tRNA Met-i , can function with imported eukaryotic-type tRNAs Met . In this study, we have used the trypanosomatid Trypanosoma brucei to investigate this problem.
Materials and Methods
Cells. Procyclic T. brucei, stock 427, was grown at 27°C in SDM-79 medium supplemented with 5% FBS. Cells were harvested at late-log phase corresponding to 2.5 to 4.5 ϫ 10 7 cells͞ml.
Isolation of Mitochondria. Mitochondria used for in organello aminoacylation and formylation assays were isolated under isotonic conditions as described (7) . The final fraction of mitochondria was resuspended at high protein concentration (30-50 mg͞ml) in SoTE (0.6 M sorbitol͞20 mM Tris⅐HCl, pH 7.5͞2 mM EDTA) containing 20 mg͞ml fatty acid-free BSA and frozen in aliquots. Mitochondria purified with this method retain an intact outer membrane and are respiration competent (8) .
In Organello Aminoacylation and Formylation Assays. All assays were done in 20 mM Tris⅐HCl, pH 7.2͞15 mM KH 2 PO 4 ͞0.6 M sorbitol͞20 mM MgSO 4 ͞5 mg/ml fatty acid-free BSA. Aminoacylation reactions were performed in 50 l containing 750 g of isotonically purified mitochondria and 20- S]cysteine (ca. 25% of total) was competed out by the addition of 0.5 mM unlabeled cysteine. Intramitochondrial ATP production was induced by the addition 5 mM ␣-ketoglutarate͞5 mM glycerol 3-phosphate͞2 mM ADP (8) . In organello formylation reactions were done as described for the aminoacylation assays, except that where applicable (see Fig. 3A ) (11) or by subjecting the sample to a deamination procedure (5) before electrophoresis. Alternatively to the gel electrophoresis, aminoacylation and formylation of tRNAs Met were also analyzed by the TLC-based procedure described below.
In Vitro Formylation Assays. Preparation of RNA-free cytosolic and mitochondrial matrix fraction was done as described (12) . Substrate tRNAs were prepared as follows. Total or mitochondrial RNA was isolated according to the acid guanidinium method (10) and separated on a preparative 8 M urea͞10% polyacrylamide gel run at pH 8.0. The region of the gel containing the tRNAs was visualized by ethidium bromide staining and cut out. After an overnight elution, the tRNAs were ethanol-precipitated and quantified by A 260 measurements.
In vitro charging and formylation assays were performed in 50 l with 30-60 g of RNA-free cytosolic or mitochondrial matrix fraction in 1ϫ acylation buffer (50 mM Tris⅐HCl, pH 7.5͞25 mM KCl͞8 mM MgCl 2 ) containing 2 mM ATP͞0.1 mM 10-formyltetrahydrofolate (THF)͞1 mM cysteine͞10 mM 2-mercaptoethanol͞0.3% (wt͞vol) CHAPS and the same amount of [ 35 S]methionine that was used for the in organello assays. The following amounts of substrate tRNAs were used: 7 g for isolated cytosolic tRNA, 3 g for isolated mitochondrial tRNAs, and 1.5 g each of gel-eluted cytosolic fraction containing either tRNA Met-e or tRNA Met-i only (see Fig. 4 ). After incubation for 15 min at 30°C, the tRNAs were reisolated by using the acid guanidinium procedure and analyzed as described for the in organello assays.
To distinguish methionylated from formylmethionylated tRNAs Met , the following procedure was developed. Isolated 35 S-labeled tRNAs from an in organello or an in vitro assay were deacylated in 15 l of 1 M Tris⅐HCl, pH 9.2, for 1-2 h at 30°C. In a next step, the tRNAs were precipitated by the addition of 2.5 vol of cold ethanol, and the sample was pelleted at 16,000 ϫ g for 20 min at 4°C. The supernatant containing the released [ 35 S]methionine or formyl[ 35 S]methionine was dried down and resuspended in 15 l of water. Finally, 2 l of each reaction was spotted on a cellulose TLC plate, which was developed in a 13:3:1 mixture of diethylether, acetic acid, and water. Unlabeled methionine and formylmethionine (2 l each) dissolved in 1 M Tris⅐HCl, pH 9.2, were used as markers and visualized by UV. The fractionated labeled amino acids were detected by using a gas flow Geiger Müller counter (TLC-linear analyzer, Berthold, Nashua, NH) and displayed on the monitor of a multichannel analyzer (system BS 27͞N, Berthold). The data shown in Figs. 3, 4, and 6 are the tracings reproduced from the pictures on the monitor. Exposure times varied from 30 min to 4 h. For all experiments, 10% of the reaction before and after the deacylation step was analyzed on an acidic 8 M urea͞10% polyacrylamide gel. This served to confirm the identity of the labeled tRNAs Met and the completeness of the deacylation as well as the integrity of the tRNA.
3-End Splint
Labeling. Quantitative 3Ј-end modification of distinct RNA species in a complex mixture of RNAs can be achieved with specific oligonucleotides and Sequenase 2.0 (United States Biochemical) by using the 3Ј-end splint-labeling protocol as originally described by Hausner et al. (13) . In this method, the oligonucleotide hybridizes to the 3Ј end of the RNA, where it leaves a 5Ј overhang that allows the enzyme to add the corresponding complementary dNTP to the 3Ј end of the selected RNA. Quantitative 3Ј-end modification of the elongator tRNA Met-e by dCTP addition was done by using the oligonucleotide (GTGGTGCGATCGGTGAGGCTCGAACTCA) and 100 M dCTP as described (14) . The control sample was treated identically except that an oligonucleotide known to modify the tRNA Lys was used (14) . After 3Ј-end modification, both tRNA fractions were subjected to in vitro aminoacylations as described above.
RNA Interference Assay. A fragment corresponding to the 5Ј part of trypanosomal MTF (nucleotide 16-509 from the ATG) was amplified by using the 5Ј primer (CCGCTCGAGGTGTGGA-CATAGTG) and the 3Ј primer (GGCAAGCTTTTCGCCATA-GACGTCG) having flanking XhoI and HindIII sites, respectively. The resulting 493-bp fragment was cloned into the corresponding restriction sites of the pZJM vector (15). The linearized vector was then transfected into the procyclic T. brucei strain 29-13, which expresses T7 RNA polymerase and the tetracycline repressor (16) . Selection and induction with tetracycline were done as described (15) . To estimate the MTFmRNA quantities in cells grown in the presence and absence of tetracycline, total RNA was isolated from an equal number of uninduced and induced cells and used for a reverse transcriptase (RT)-PCR analysis by using avian myeloblastosis virus reverse transcriptase (Promega) and the same set of primers as above. Previous experiments have demonstrated that this method yields semiquantitative results if analyzed in the linear range of the amplification. Finally, in organello formylation activity was compared in both cell lines. Washed cells (10 8 cells each) of cultures grown in the presence and the absence of tetracycline were resuspended in 0.5 ml of SoTE; 0.5 ml of SoTE containing 0.025% (wt͞vol) of digitonin was added, and the sample was mixed by pipetting and incubated on ice for 5 min. After centrifugation (8,000 ϫ g for 5 min at 4°C), the supernatant was discarded, and the resulting mitochondrial pellet was resuspended in 250 l of the buffer used for the in organello formylation assays. Control experiments have shown that the mitochondrial fraction obtained by digitonin treatment is capable of respiratory substrate-driven ATP production. The labeling reaction and the analysis of the labeled products was done as described for the in organello assays.
Miscellaneous. Northern blots were done as described (17) . The indicated oligonucleotides directed against the T-stem loop region were used for the specific detection of tRNA Met-i (GT-TGGTTTCGATCCAACG) and tRNA Met-e (GTGAGGCTC-GAACTCACG).
Results tRNAs Met in T. brucei. Analysis of the nearly complete genomic sequence of T. brucei (kindly provided by The Institute for Genomic Research and the Sanger Centre) has identified genes for two distinct but homologous tRNAs Met whose predicted secondary structures are shown in Fig. 1A . One resembles a standard elongator tRNA Met-e ; the other one has an A1⅐U72 base pair and three consecutive G⅐C base pairs at the end of the anticodon stem and therefore corresponds to the cytosolic initiator tRNA Met-i (1) . Northern analysis by using oligonucleotides specifically hybridizing to either of the two tRNAs Met is depicted in Fig. 1B . The left panel shows that a band is detected in total cellular RNA, which in size corresponds closely to the in vitro transcript of the elongator tRNA Met-e . The band was detected in both RNA isolated from whole cells as well as from the mitochondrial fraction, indicating that the tRNA is in part imported into mitochondria. The right panel shows the analogous experiment for the initiator tRNA Met-i , which is found in the cytosol only. In this case, the in vitro transcript migrates a bit slower than the molecules detected in isolated RNA fractions, which is due to the fact that it is one nucleotide longer than the expected mature tRNA.
Are there other as yet undetected tRNAs Met in T. brucei? This is clearly possible, as in a recent genome-wide analysis it was concluded that only 80% of all trypanosomal tRNA genes have been identified (R. Pach and A.S., unpublished results). To detect all existing tRNAs Met , we performed aminoacylation assays by using RNA-free cytosol as source of enzyme and total cellular tRNAs as substrate. Fig. 2A (Upper) shows that two charged tRNA Met species are present in the cell. The slower migrating one corresponds in size to the charged in vitro transcript of the elongator tRNA Met-e , whereas the other one comigrates with the corresponding signal for initiator tRNA Met-i (data not shown). Separate experiments confirmed that the signals of both charged tRNA species coincide with the signals obtained on Northern blots (data not shown). To exclude that a second, as yet unidentified tRNA Met , which comigrates with the known elongator tRNA Met , is contributing to the observed aminoacylation signal, further charging assays were performed. In these assays, we used a total tRNA fraction in which the 3Ј-end of the elongator tRNA Met-e was quantitatively modified by 3Ј-end splint labeling (13, 14, 18) as a substrate (see Material and Methods). (even on high resolution gels) but also to share the same 3Ј sequence. Thus, the only two bands detected by aminoacylation (Fig. 2 A) can be assigned to the two known trypanosomal tRNAs Met-e by 3Ј-end splint labeling results in a complete loss of the observed aminoacylation signal (Fig. 2B Lower) . Thus, the imported elongator tRNA Met-e seems to be the only tRNA Met that is present in mitochondria. In both experiments, the radioactive label is sensitive to deacylation at pH 9.2, indicating that the label is on the amino acid. Thus, it is concluded that formylation of a tRNA species that, in size, corresponds to the elongator tRNA
Met-e occurs in T. brucei mitochondria. In the second approach, we established a method that allows the direct detection of formyl-methionine. Aminoacylation assays by using [ 35 S]methionine were performed either in energized mitochondria or in vitro in the presence of ATP and the formyl donor 10-formyl-THF. After incubation, [ 35 S]methionine-labeled RNA was isolated and incubated at pH 9.2. This condition results in the release of the charged amino acid, which is then analyzed by TLC optimized to separate methionine from its formylated derivative. Using this protocol, it was shown that from crude cytosolic extract containing RNA and proteins, the only 35 S-labeled molecule released during the deacylation reaction was methionine (Fig. 3B Upper) . In an in organello formylation assay, however, not only [ (Fig. 3B Lower) . The obtained results are in full agreement with the formate-labeling experiment discussed before (Fig. 3A) and show that a significant fraction (40-50%, depending on the experiment) of the elongator methionyl-tRNA Met-e is formylated in mitochondria of T. brucei.
To look at the substrate specificity of the activity in some more detail, we performed further types of in vitro formylation assays.
As a source of enzyme we used RNA-free cytosolic and mitochondrial matrix fractions (see Materials and Methods). These fractions were incubated with ATP, [ 35 S]methionine, and 10-formyl-THF by using both crude total tRNA or isolated mitochondrial tRNAs as substrates. Fig. 4A Left shows that cytosolic extract is able to charge both the cytosolic as well as the mitochondrial tRNAs Met but is devoid of formylation activity. The mitochondrial matrix, on the other hand, shows both methionyl-tRNA synthetase as well as formylation activity, as evidenced by the two peaks that are detected by TLC (Fig. 4A  Right) . Interestingly, the mitochondrial activity not only formylates isolated mitochondrial tRNAs but, to a lesser extent, also cytosolic tRNAs. The cytosolic tRNA fraction contains both the cytosol-specific initiator tRNA Met-i as well as the nonimported fraction (ca. 94% of total) of elongator tRNA
Met-e (R. Pach and A.S., unpublished results). To see which of the two molecules in the cytosolic fraction is formylated in the in vitro reaction, the two tRNAs Met were separated from each other and eluted from a denaturing polyacrylamide gel. Fig. 4B Left shows that elongator tRNA Met-e from the cytosolic fraction is formylated by the matrix-localized activity with similar efficiency to the elongator tRNA Met-e of mitochondrial origin. The formylation activity therefore does not discriminate between cytosolic and mitochondrial isotype of elongator tRNA Met-e . Indeed, extensive RT-PCR analysis suggests that elongator tRNAs Met-e isolated from mitochondria and from the cytosol have identical nucleotide sequences (not shown). The cytosol-specific initiator tRNA Met-i , however, cannot be formylated. This is surprising, as the eukaryotic-type initiator tRNA Met-i more closely resembles the mitochondrial initiator tRNA Met-i of other organisms than does the trypanosomal elongator tRNA Met-e . In vitro formylation assays were also performed by using in vitro transcribed elongator tRNA Met-e as substrates. Whereas the synthetic tRNA
Met-e could be charged efficiently (Fig. 2 A, right lane) , the in vitro transcript could not be formylated, indicating an essential role for a nucleotide or base modification for the recognition by the trypanosomal MTF (data not shown).
The Gene for Mitochondrial MTF of T. brucei. To identify the gene encoding the formylation activity, we searched the T. brucei genomic databases (kindly provided by The Institute of Genomic Upper) and gel-eluted mitochondrial tRNAs (MIT tRNA, Lower) were used as substrates in the experiments. (B) Gel-purified tRNA Met-e (E1) or tRNA Met-i (E2) originating from total cellular RNA were tested. The low intensity signal migrating slower than methionine was specific for the isotope mixture from Hartmann Analytic and was not found if the Amersham Pharmacia product was used. It coincides with the position of a cysteine marker. The positions of unlabeled methionine (Met) and formyl-methionine (fMet) are indicated as in Fig. 3 . The purity of the eluted tRNA fractions, regarding the initiator and elongator tRNAs Met , was tested by the Northern blots shown (Right), which were probed with the same oligonucleotides that were used in Fig. 1 .
Research and the Sanger Centre) with the default BLAST algorithm by using bacterial and mitochondrial MTF amino acid sequences as templates. The obtained genomic fragments allowed us to assemble a contig corresponding to a complete ORF. Expression of this ORF was confirmed by amplification of the corresponding cDNA by using an oligo(dT) primer and a genespecific primer hybridizing to the 5Ј-untranslated region of the mRNA. Furthermore, analysis of the cDNA showed that its sequence is identical to the genomic DNA. An alignment of the predicted protein sequence of this ORF with two mitochondrial (cattle, yeast) and two bacterial MTFs (Deinococcus radiodurans, E. coli) is shown in Fig. 5 . If the ORF of the trypanosomal gene is compared with the complete nonredundant database, the only homologous proteins detected are bacterial and mitochondrial MTFs. The amino terminus of the putative trypanosomal MTF is predicted to have a mitochondrial targeting sequence when analyzed with the iPSORT or MITOPROT programs. Interestingly, however, the predicted trypanosomal protein is approximately twice the size of all other MTFs.
Recently, it was shown that the phenomenon of RNA interference does occur in T. brucei and can be used to inhibit expression of specific genes (15, 19, 20) . We therefore used this technique to test whether the identified ORF indeed encodes the trypanosomal MTF. To do so, we established a stable cell line expressing sense and antisense strands of the 5Ј-segment of the putative MTF gene under the control of two opposing tetracycline-inducible T7 RNA polymerase promoters (16) . The RT-PCR experiments in Fig. 6B show the mRNA level of the trypanosomal MTF homologue drops below detectable levels after addition of the antibiotic. Equal numbers of cells grown in the presence or the absence of tetracycline were subjected to digitonin treatment to obtain a crude mitochondrial fraction (see Materials and Methods). Both organellar fractions were then used for in organello formylation assays identical to the ones described before (Fig. 3B) , and the formylation state of the imported elongator tRNA Met-e was analyzed by TLC (Fig. 6C) . The experiment showed that methionyl-tRNA synthetase activity was comparable in both samples, but the formylation activity was greatly reduced in mitochondria from the cells grown in the presence of tetracycline. The formylated fraction of the elongator tRNA Met-e (ca. 50%) in the cells grown in the absence of tetracycline was larger than in the experiments shown in Fig. 3B (ca. 40%), which could be due to the fact that different mitochondrial isolation procedures and cell lines were used in the two experiments. The cells with reduced formylation activity did not show a growth phenotype (Fig. 6A) , which might be because there is still enough of the enzyme left to support normal growth. Thus, we conclude that the characterized ORF indeed encodes the trypanosomal MTF and that it is this enzyme that is responsible for the formylation of the imported elongator methionyl-tRNA Met-e in T. brucei.
Discussion
As expected for a eukaryote, two distinct tRNAs Moreover, only the elongator tRNA Met-e is imported into mitochondria, indicating that initiation and elongation of organellar translation must use a single tRNA Met . This is not unusual, as many mitochondria have only a single tRNA Met , which, however, shows at least some structural features of typical initiator tRNAs Met (3). In T. brucei, the situation is very different because the imported tRNA Met is apparently identical to the one that is used in cytosolic elongation. A hallmark of bacterial-type translation is that it uses formylated tRNA Met-i . Interestingly, formylation of tRNA Met still occurs in T. brucei mitochondria, even though an initiator-type tRNA Met is absent. T. brucei therefore has a MTF that naturally recognizes elongator tRNA Met-e . Thus, the substrate specificity of the trypanosomal MTF is diametrically opposed to bacterial or mitochondrial MTFs, which in vivo only formylate initiator and not elongator tRNAs Met . The bovine mitochondrial MTF, which is the only mitochondrial MTF characterized so far (21) , has a relaxed substrate specificity when compared with the bacterial enzyme, especially concerning the acceptor stem region of the substrate tRNA Met (3). The trypanosomal elongator tRNA Met-e , however, is devoid of all of the known structural features that are recognized by the mitochondrial MTF in the bovine system. Neither the first three acceptor stem base pairs of the bovine substrate nor the purine11⅐pyrimidine-24 base pairs conserved in most initiator tRNAsMet are found in trypanosomal tRNA Met-e . In agreement with this, it was shown that the bovine MTF has only residual activity (0.2% when compared with the natural substrate) when tested with elongator tRNA Met of E. coli (3) . The features of the trypanosomal elongator tRNA Met-e that are recognized by the mitochondrial MTF are also present in the cytosolic fraction of the elongator tRNA Met-e . A mitochondrial tRNA-editing event as prerequisite for formylation can therefore be excluded. Furthermore, in vitro experiments have shown that the enzyme can discriminate between the elongator tRNA Met-e and the homologous cytosol-specific initiator tRNA Met-i . In vitro transcribed elongator tRNA Met-e , on the other hand, can be aminoacylated but not formylated when treated with mitochondrial extract. This suggests that a nucleotide or base modification is required as a recognition element for the trypanosomal MTF.
Mining the genome database and RNA interference assay allowed us to identify the gene responsible for the mitochondrial MTF activity in T. brucei. An alignment of three mitochondrial and two bacterial MTFs is shown in Fig. 5 . The general structure of MTFs consisting of two domains that are separated by a linker region seems to be retained in trypanosomes (22, 23) . Interestingly, the linker region (at position 313-368) is longer than in any of the other enzymes. Most strikingly, however, is the fact that the protein is approximately twice the size of any other MTFs. The larger size of the trypanosomal protein is mainly because of unique amino-terminal (ca. 40 aa) and carboxyl-terminal (ca. 110 aa) extensions as well as to four internal insertions (13-22 aa) . As for the bovine mitochondrial MTF (3), no obvious sequence element corresponding to the previously described 16-aa insertion sequence in the amino-terminal domain of the E. coli enzyme (22) is found in the trypanosomal enzyme. This element is responsible for interaction with the acceptor stem of the tRNA Met-i (24) ; its absence might therefore by explained by the fact that the trypanosomal enzyme must recognize the acceptor stem of an elongator-type tRNA Met-e . In summary, we have shown that in T. brucei, a single gene product, the nucleus-encoded elongator tRNA Met-e , has three distinct functions in two cellular compartments. It is required for translation elongation in the cytosol and for both the initiation and elongation step in mitochondrial translation. A fraction of the imported elongator methionyl-tRNA
Met-e becomes formylated in mitochondria. This formylation is carried out by an unusual MTF, which compared with the corresponding enzymes in other cells, has an inversed specificity concerning the tRNA substrate and selectively recognizes elongator tRNA Met-e . Besides the unusual MTF described in this study, there are other examples for adaptations of the trypanosomatid mitochondrial translation system to eukaryotic-type tRNAs. In Leishmania mitochondria, a C to U RNA-editing event in the anticodon of the imported tRNA Trp (CCA) allows the decoding of UGG and UGA codons. The unedited tRNA Trp (CCA) in the cytosol, however, as required reads the standard UGG tryptophan codon only (25) . Finally, whereas organelles are known to be devoid of glutaminyl-tRNA synthetases, as their tRNAs are charged in a two-step process requiring a tRNA-dependent transamidase (9), such enzymes exist in trypanosomatid mitochondria (12) . Thus, exploring the limits of adaptation of a bacterial-type translation system to eukaryotic components may help to reveal fundamental requirements of translation.
